NRIP, a novel calmodulin binding protein, activates calcineurin to dephosphorylate human papillomavirus E2 protein

Journal of Virology

Volumn 85, Issue 13, 2011, Pages 6750-6763

  Chang, Szu Wei ^a   Tsao, Yeou Ping ^b   Lin, Chia Yi ^a   Chen, Show Li ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM; CALMODULIN BINDING PROTEIN; E2 PROTEIN; NRIP PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; IQWD1 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NRIP GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STABILITY; UBIQUITINATION; VIRUS GENE; CELL LINE; CELL STRAIN HEK293; GENETICS; METABOLISM; PHOSPHORYLATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

CALCINEURIN; CALMODULIN-BINDING PROTEINS; CELL LINE; DNA-BINDING PROTEINS; HEK293 CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PHOSPHORYLATION;

EID: 80052062575     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02453-10     Document Type: Article

References (52)

1. Backs, J., T. Backs, S. Bezprozvannaya, T. A. McKinsey, and E. N. Olson. 2008. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol. Cell Biol. 28:3437-3445
2. Bahler, M., and A. Rhoads. 2002. Calmodulin signaling via the IQ motif. FEBS Lett. 513:107-113.
3. Bellanger, S., C. Demeret, S. Goyat, and F. Thierry. 2001. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 75:7244-7251.
4. Bellanger, S., C. L. Tan, W. Nei, P. P. He, and F. Thierry. 2010. The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase. J. Virol. 84:437-444.
5. Berridge, M. J., P. Lipp, and M. D. Bootman. 2000. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1:11-21.
6. Bikle, D. D., Y. Oda, and Z. Xie. 2005. Vitamin D and skin cancer: a problem in gene regulation. J. Steroid Biochem. Mol. Biol. 97:83-91.
7. Chen, P. H., Y. P. Tsao, C. C. Wang, and S. L. Chen. 2008. Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability. Nucleic Acids Res. 36:51-66.
8. Gagnon, D., et al. 2009. Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4. J. Virol. 83:4127-4139.
9. Gammoh, N., D. Gardiol, P. Massimi, and L. Banks. 2009. The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2. J. Virol. 83:1538-1543.
10. Garcia-Alai, M. M., et al. 2006. Molecular basis for phosphorylation-dependent, PEST-mediated protein turnover. Structure 14:309-319.
11. Hamid, N. A., C. Brown, and K. Gaston. 2009. The regulation of cell proliferation by the papillomavirus early proteins. Cell Mol. Life Sci. 66:1700- 1717.
12. Han, C. P., et al. 2008. Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization. J. Exp. Clin. Cancer Res. 27:25.
13. Higa, L. A., et al. 2006. CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat. Cell Biol. 8:1277-1283.
14. Huang, C. C., et al. 2008. Calcineurin-mediated dephosphorylation of c-Jun Ser-243 is required for c-Jun protein stability and cell transformation. Oncogene 27:2422-2429.
15. Hubbert, N. L., J. T. Schiller, D. R. Lowy, and E. J. Androphy. 1988. Bovine papilloma virus-transformed cells contain multiple E2 proteins. Proc. Natl. Acad. Sci. U. S. A. 85:5864-5868.
16. Jia, S., R. Kobayashi, and S. I. Grewal. 2005. Ubiquitin ligase component Cul4 associates with Clr4 histone methyltransferase to assemble heterochromatin. Nat. Cell Biol. 7:1007-1013.
17. Jin, J., E. E. Arias, J. Chen, J. W. Harper, and J. C. Walter. 2006. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol. Cell 23:709-721.
18. Kahl, C. R., and A. R. Means. 2003. Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr. Rev. 24:719-736.
19. Kinoshita-Kikuta, E., Y. Aoki, E. Kinoshita, and T. Koike. 2007. Label-free kinase profiling using phosphate affinity polyacrylamide gel electrophoresis. Mol. Cell Proteomics 6:356-366.
20. Komuves, L., et al. 2002. Epidermal expression of the full-length extracellular calcium-sensing receptor is required for normal keratinocyte differentiation. J. Cell Physiol. 192:45-54.
21. Kotake, Y., Y. Zeng, and Y. Xiong. 2009. DDB1-CUL4 and MLL1 mediate oncogene-induced p16INK4a activation. Cancer Res. 69:1809-1814.
22. Kovelman, R., G. K. Bilter, E. Glezer, A. Y. Tsou, and M. S. Barbosa. 1996. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses. J. Virol. 70:7549-7560.
23. Kumar, R. A., S. R. Naidu, X. Wang, A. N. Imbalzano, and E. J. Androphy. 2007. Interaction of papillomavirus E2 protein with the Brm chromatin remodeling complex leads to enhanced transcriptional activation. J. Virol. 81:2213-2220.
24. Lee, A. Y., and C. M. Chiang. 2009. Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability. J. Biol. Chem. 284:2778-2786.
25. Lee, C. W., et al. 2008. Tumor necrosis factor-alpha enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells. Mol. Pharmacol. 73:1454-1464.
26. Lee, D., S. G. Hwang, J. Kim, and J. Choe. 2002. Functional interaction between p/CAF and human papillomavirus E2 protein. J. Biol. Chem. 277: 6483-6489.
27. Little, G. H., Y. Bai, T. Williams, and C. Poizat. 2007. Nuclear calcium/ calmodulin-dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cells. J. Biol. Chem. 282:7219-7231.
28. Longworth, M. S., and L. A. Laimins. 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68:362- 372.
29. Lusky, M., and E. Fontane. 1991. Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1. Proc. Natl. Acad. Sci. U. S. A. 88:6363-6367.
30. McBride, A. A., M. G. McPhillips, and J. G. Oliveira. 2004. Brd4: tethering, segregation and beyond. Trends Microbiol. 12:527-529.
31. McBride, A. A., J. G. Oliveira, and M. G. McPhillips. 2006. Partitioning viral genomes in mitosis: same idea, different targets. Cell Cycle 5:1499-1502.
32. Moody, C. A., and L. A. Laimins. 2010. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 10:550-560.
33. Muller, A., A. Ritzkowsky, and G. Steger. 2002. Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J. Virol. 76:11042-11053.
34. Ng, D. C., M. J. Su, R. Kim, and D. D. Bikle. 1996. Regulation of involucrin gene expression by calcium in normal human keratinocytes. Front. Biosci. 1:a16-24.
35. Parkin, D. M., F. Bray, J. Ferlay, and P. Pisani. 2005. Global cancer statistics, 2002. CA Cancer J. Clin. 55:74-108.
36. Peng, Y. C., D. E. Breiding, F. Sverdrup, J. Richard, and E. J. Androphy. 2000. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J. Virol. 74:5872-5879.
37. Penrose, K. J., M. Garcia-Alai, G. de Prat-Gay, and A. A. McBride. 2004. Casein kinase II phosphorylation-induced conformational switch triggers degradation of the papillomavirus E2 protein. J. Biol. Chem. 279:22430- 22439.
38. Penrose, K. J., and A. A. McBride. 2000. Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. J. Virol. 74:6031-6038.
39. Rehtanz, M., H. M. Schmidt, U. Warthorst, and G. Steger. 2004. Direct interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcription. Mol. Cell Biol. 24:2153- 2168.
40. Rhoads, A. R., and F. Friedberg. 1997. Sequence motifs for calmodulin recognition. FASEB J. 11:331-340.
41. Scrima, A., et al. 2008. Structural basis of UV DNA-damage recognition by the DDB1-DDB2 complex. Cell 135:1213-1223.
42. Thierry, F. 2009. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 384:375-379.
43. Tsai, T. C., Y. L. Lee, W. C. Hsiao, Y. P. Tsao, and S. L. Chen. 2005. NRIP, a novel nuclear receptor interaction protein, enhances the transcriptional activity of nuclear receptors. J. Biol. Chem. 280:20000-20009.
44. Tu, C. L., W. Chang, and D. D. Bikle. 2001. The extracellular calcium-sensing receptor is required for calcium-induced differentiation in human keratinocytes. J. Biol. Chem. 276:41079-41085.
45. Vetter, S. W., and E. Leclerc. 2003. Novel aspects of calmodulin target recognition and activation. Eur. J. Biochem. 270:404-414.
46. Wang, X., S. R. Naidu, F. Sverdrup, and E. J. Androphy. 2009. Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability. J. Virol. 83:2274-2284.
47. Wu, M. H., J. Y. Chan, P. Y. Liu, S. T. Liu, and S. M. Huang. 2007. Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells. Int. J. Biochem. Cell Biol. 39:413-425.
48. Wu, S. Y., et al. 2006. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 20:2383-2396.
49. Yao, J. M., D. E. Breiding, and E. J. Androphy. 1998. Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB. J. Virol. 72:1013-1019.
50. You, J., J. L. Croyle, A. Nishimura, K. Ozato, and P. M. Howley. 2004. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117:349-360.
51. Zheng, G., et al. 2009. Brd4 regulation of papillomavirus protein E2 stability. J. Virol. 83:8683-8692.
52. zur Hausen, H. 2009. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384:260-265.